Master of Science I (Genetics) Examination: Oct Nov 2016
Semester I (New CBCS)
SLR No. Day
Date Time Subject Name Paper
No. Seat No.
SLR SQ
442
Wednesday
23/11/2016
10.30 AM
to
01.00 PM
Clinical Bioinformatics
C
SCT 1.2
Instructions: Part Question 1 is compulsory.
Attempt any four questions from Part II.
Figures to the right indicate full marks.
Answers to the Part-I and Part-II are to be written in same
answer Booklet only.
Total Marks: 70
PART I
Q.1 Rewrite the sentences after choosing the correct answers from the given
alternative.
07
is a joint scientific project between the European
Bioinformatics Institute and the Wellcome Trust Sanger Institute.
NCBI Ensemble
Swiss-Port BioMart
FastQC next generation sequencing tool is tool on platform.
Illumine FASTQ
GNU Glib CASAVA
R is an language; users typically access it though a command
line interpreter.
Object oriented Structure oriented
Interpreted All
CPT is a registered trademark of the medical association.
American Indian
Australian All of above
International statistical classification of Diseases is developed by

Sanger WHO
ICHI ICF
can be used to filter, reformat, or trim your genomic and
metagenomic sequence data.
HTQC QPLOT
PRINSEQ FASTX
The first pathogen genome that of was sequenced by
traditional Sanger methods.
Haemophilus influenza Staphylococcus epidermidis
Staphylococcus aureus Neisseria meningitides
Page 1 of 2
Definitions: 07
Pathogen
Neurodegenerative disorders
Metobolites
Clinical trial
Mapviewer
Epigenomics
Annotation
PART II
Answer any four of the following.
Q.2 Define NGS. Add a note on its tools and techniques. 14
Q.3 Write a detailed note on pathology informatics with examples. 14
Q.4 Explain the different challenges and applications of pharmacogenomics. 14
Q.5 Answers any two 14
Add a note on microarray with types
Write a note on medical coding with applications.
Explain the implications of genome projects in human health disease.
Q.7 Write short note on any two 14
Transcriptomics
System Biology
Pharmacoviglance